Literature DB >> 17823271

Human immunodeficiency virus (HIV) gag antigen-specific T-helper and granule-dependent CD8 T-cell activities in exposed but uninfected heterosexual partners of HIV type 1-infected individuals in North India.

Suresh Pallikkuth1, Ajay Wanchu, Archana Bhatnagar, Ravinder Kaur Sachdeva, Meera Sharma.   

Abstract

Repeated exposure to human immunodeficiency virus (HIV) does not always result in HIV infection, and several cohorts of HIV-exposed but uninfected (EU) individuals have been described. We studied T-helper and granule-dependent cytotoxic T-lymphocyte (CTL) activities in a group of 30 EU partners of HIV type 1 (HIV-1)-infected individuals. HIV-1-specific helper-T-cell activity was studied by measuring the levels of interleukin 2 (IL-2) produced by peripheral blood mononuclear cells (PBMCs) and the granule-dependent CTL activity by measuring the intracellular levels of perforin and granzyme B expression in CD8+ T cells after stimulation with gag p24 antigen. Elevated IL-2 production by PBMCs after p24 stimulation occurred in EU individuals. The levels of perforin and granzyme B expression in CD8+ T cells were also higher among EU individuals than among healthy controls. HIV-specific helper-T-cell and granule-dependent CTL activities inversely correlated with the time since the last unprotected sexual exposure in these individuals. In our cohort, activation of T-helper and granule-dependent CTL activities against HIV might be due to unprotected sexual contact. These results indicate that HIV-1-specific T-cell responses could play a role in protection against acquiring infection in this cohort of EU individuals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823271      PMCID: PMC2043305          DOI: 10.1128/CVI.00488-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  37 in total

1.  Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses.

Authors:  R Kaul; S L Rowland-Jones; J Kimani; T Dong; H B Yang; P Kiama; T Rostron; E Njagi; J J Bwayo; K S MacDonald; A J McMichael; F A Plummer
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

2.  Activation of HIV-1 specific CD4 and CD8 T cells by human dendritic cells: roles for cross-presentation and non-infectious HIV-1 virus.

Authors:  Marie Larsson; Jean-Francois Fonteneau; Margareta Lirvall; Patrick Haslett; Jeffrey D Lifson; Nina Bhardwaj
Journal:  AIDS       Date:  2002-07-05       Impact factor: 4.177

3.  CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.

Authors:  L Lopalco; C Barassi; C Pastori; R Longhi; S E Burastero; G Tambussi; F Mazzotta; A Lazzarin; M Clerici; A G Siccardi
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

4.  CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects.

Authors:  R Kaul; T Dong; F A Plummer; J Kimani; T Rostron; P Kiama; E Njagi; E Irungu; B Farah; J Oyugi; R Chakraborty; K S MacDonald; J J Bwayo; A McMichael; S L Rowland-Jones
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

5.  Factors affecting the efficiency of CD8+ T cell cross-priming with exogenous antigens.

Authors:  H T Maecker; S A Ghanekar; M A Suni; X S He; L J Picker; V C Maino
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

6.  Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure.

Authors:  Joan H Skurnick; Paul Palumbo; Anthony DeVico; Barbara L Shacklett; Fred T Valentine; Michael Merges; Roberta Kamin-Lewis; Jiri Mestecky; Thomas Denny; George K Lewis; Joan Lloyd; Robert Praschunus; Amanda Baker; Douglas F Nixon; Sharon Stranford; Robert Gallo; Sten H Vermund; Donald B Louria
Journal:  J Infect Dis       Date:  2002-01-17       Impact factor: 5.226

7.  Perforin expression in T cells and virological response to PEG-interferon alpha2b in HIV-1 infection.

Authors:  Pierre Portales; Jacques Reynes; Régine Rouzier-Panis; Vincent Baillat; Jacques Clot; Pierre Corbeau
Journal:  AIDS       Date:  2003-03-07       Impact factor: 4.177

8.  Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects.

Authors:  Claudia Devito; Jorma Hinkula; Rupert Kaul; Joshua Kimani; Peter Kiama; Lucia Lopalco; Claudia Barass; Stefania Piconi; Daria Trabattoni; Job J Bwayo; Francis Plummer; Mario Clerici; Kristina Broliden
Journal:  J Acquir Immune Defic Syndr       Date:  2002-08-01       Impact factor: 3.731

9.  Evidence for Gag p24-specific CD4 T cells with reduced susceptibility to R5 HIV-1 infection in a UK cohort of HIV-exposed-seronegative subjects.

Authors:  Josiah Eyeson; Deborah King; Mark J Boaz; Eseberuo Sefia; Sarah Tomkins; Anele Waters; Philippa J Easterbrook; Annapurna Vyakarnam
Journal:  AIDS       Date:  2003-11-07       Impact factor: 4.177

10.  HIV-specific T helper responses and frequency of exposure among HIV-exposed seronegative female sex workers in Abidjan, Cote d'Ivoire.

Authors:  Wim Jennes; Bea Vuylsteke; Marie-Yolande Borget; Virginie Traore-Ettiegne; Chantal Maurice; Monica Nolan; John N Nkengasong; Luc Kestens
Journal:  J Infect Dis       Date:  2004-01-29       Impact factor: 5.226

View more
  7 in total

1.  Differential regulatory T cell activity in HIV type 1-exposed seronegative individuals.

Authors:  Laura Pattacini; Pamela M Murnane; Erin M Kahle; Michael J Bolton; Jeffrey J Delrow; Jairam R Lingappa; Elly Katabira; Deborah Donnell; M Juliana McElrath; Jared M Baeten; Jennifer M Lund
Journal:  AIDS Res Hum Retroviruses       Date:  2013-07-30       Impact factor: 2.205

Review 2.  Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).

Authors:  C Tomescu; S Abdulhaqq; L J Montaner
Journal:  Clin Exp Immunol       Date:  2011-03-17       Impact factor: 4.330

3.  CCR5 expression, haplotype and immune activation in protection from infection in HIV-exposed uninfected individuals in HIV-serodiscordant relationships.

Authors:  Shameem Z Jaumdally; Anabela Picton; Caroline T Tiemessen; Maria Paximadis; Heather B Jaspan; Hoyam Gamieldien; Lindi Masson; David Coetzee; Anna-Lise Williamson; Francesca Little; Pamela P Gumbi; Jo-Ann S Passmore
Journal:  Immunology       Date:  2017-05-24       Impact factor: 7.397

4.  Impacts of HIV infection on Vgamma2Vdelta2 T cell phenotype and function: a mechanism for reduced tumor immunity in AIDS.

Authors:  Jean-Saville Cummings; Cristiana Cairo; Cheryl Armstrong; Charles E Davis; C David Pauza
Journal:  J Leukoc Biol       Date:  2008-05-21       Impact factor: 4.962

5.  Genetic and Immunological Factors Involved in Natural Resistance to HIV-1 Infection.

Authors:  Natalia Taborda-Vanegas; Wildeman Zapata; María Teresa Rugeles
Journal:  Open Virol J       Date:  2011-05-11

Review 6.  Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.

Authors:  Nadia Chanzu; Beatrice Ondondo
Journal:  Front Immunol       Date:  2014-05-08       Impact factor: 7.561

Review 7.  Role of Different Subpopulations of CD8+ T Cells during HIV Exposure and Infection.

Authors:  Sandra Milena Gonzalez; Natalia Andrea Taborda; María Teresa Rugeles
Journal:  Front Immunol       Date:  2017-08-07       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.